Paris, October 3, 2018 – Ardian, a world-leading private investment house, today announces that it has signed an agreement to acquire a majority stake in Inula Group from Vendis Capital, Dominique Baudoux (Founder & Chairman) and Sergio Calandri (CEO).
Inula Group was created following the merger of Pranarôm and HerbalGem, two pioneering laboratories specialized in natural therapies, founded in 1985 and 1986 respectively. Inula is a key player in the herbal remedies market, specializing in fast growing sub-sectors such as aromatherapy, gemmotherapy and Bach flowers, through three brands: Pranarôm, HerbalGem and Biofloral. Thanks to its strong scientific approach and the quality of its products, the Group has experienced significant growth over the past years and is now present in more than 25 countries, with leading positions in France, Belgium, Spain, Italy and the USA.
As part of this transaction, Sergio Calandri, CEO of Inula, will reinvest alongside Ardian. Vendis Capital and Pranarôm’s Founder, Dominique Baudoux, should also continue to support the Group.
Bruno Ladrière, Managing Director, Ardian Buyout, and Daniel Setton, Director, said: “We are pleased to be partnering with Inula’s team and we thank them for the confidence they expressed during this operation. We look forward to supporting them in the next phase of the company’s development, helping them reinforce Pranarôm, HerbalGem and Biofloral in their segments in Europe and globally. This transaction is a good example of Ardian’s expertise in supporting SMEs in their ambitious growth strategy.”
Cedric Olbrechts, Partner at Vendis Capital and Dominique Baudoux Founder & Chairman of Inula said: “During our seven-year partnership, we worked together to create a strong dynamic, respecting the role and skills of each other. As a result, the Group has become a leader in natural medicines in Europe, has expanded its international presence, has opened new distribution channels and has developed new products, under the brand Pranarôm but also thanks to the successful integrations of HerbalGem, Biofloral and Veriditas. We are very happy and proud to have achieved the plan we set up in 2011. All these successes belong above all to the high quality and passionate team led by Sergio Calandri. We would like therefore to warmly thank everyone for their commitment, work and talent.” Dominique Baudoux, added: “It quickly became clear to me that Ardian was the right partner to support the Group, because, more than any other potential partner, their approach is in line with the core values which have guided us since the creation of the company.”
Sergio Calandri, CEO of Inula, said: “We have achieved strong growth over the past years, establishing our brands as leaders across Europe and overseas, as well as successfully integrating selected acquisitions. The key points that differentiate our approach (the quality of our products, our scientific approach, our focus on client training and the control of all the stages of the manufacturing process) will remain the key pillars of our future development. Ardian is the ideal partner to accompany Inula on this next development phase, thanks notably to its strong experience in the healthcare sector and its international network.”
ABOUT VENDIS CAPITAL
LIST OF PARTICIPANTS
Buyer: Ardian (Bruno Ladrière, Daniel Setton, Alexis Manet, Rafik Alili, Edmond Delamalle)Seller Advisors:
M&A Advisors : JP Morgan (Edouard Debost, Peter Hujoel, Sebastien Guiol)
M&A Lawyer: Freshfields (Vincent Macq, Frederic Elens, Elliott Fosseprez)
Management Lawyer: Laurius (David Ryckaert)
Finance VDD: PwC (Philippe Estas, Geoffroy Jonckheere, Arnaud Chantraine, Olivier Van Crombrugge)
Fiscal VDD: PwC (Hugues Lamon, Koen Walbers)
Strategic VDD: Roland Berger (Grégoire Tondreau, Patrick Biecheler, Pierre-Antoine Bodin, Jean Muraire, Yaroslav Stetsenko)
Regulatory VDD: Covington (Bart Van Vooren)
M&A Advisors: BNP Paribas Fortis (Gabriel Englebert, Pieter-Jan Van de Walle, Wide Hellemans, Elena Coluccelli-Guérin, Muriel Petit)
Lawyer: Latham (Olivier du Mottay, Bénédicte Bremond, Lionel Dechmann)
Financing Advisors: EY (Yannick Lostie de Kerhor, Stéphane Seguin, Mathieu Creuzet, Nicolas Morel)
Legal, fiscal, social and CSR Advisors: EY (Jean-Christophe Sabourin, Patrice Mottier, Tom Swinnen, Lionel Benant, Anne Dupupet, Anne-Elisabeth Combes, Maelle Duquoc)
Insurance Advisors: Siaci St Honoré (Pierre de Rochebouet, Julie Marmara, Brigitte Lalo)
Strategic Advisors: EY-Parthenon (Henri-Pierre Vacher, Vincent Czeszynski, Louis Ravier, Benjamin Ferrand, Fabien Bouskila)
Regulatory Advisors: InnoveoCare (Géraldine Veuillet, Elodie Demars)